Clinical trial
Short Course of Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
NCT01300975 is registered in ClinicalTrials.gov with Fundacion Nacional de Dermatologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short Course of Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
- Lead sponsor
- Fundacion Nacional de Dermatologia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- July 31, 2012
- Enrollment
- 90 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous leishmaniasis, leishmaniasis